Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest Varicella zoster virus Stories

2006-05-26 13:08:32

By Toni Clarke and Susan Heavey BOSTON/WASHINGTON (Reuters) - U.S. health officials on Friday approved the first vaccine to prevent shingles, a painful disease characterized by a blistering rash that affects nearly 1 million, mostly older adults every year. The vaccine, Zostavax, which is made by Merck & Co. and aims to boost the immune system, was approved for adults age 60 and older. Shingles is caused by a reactivation of the virus that causes chickenpox. Treatments generally...

2005-12-14 13:35:30

By Susan Heavey WASHINGTON (Reuters) - Studies show Merck & Co. Inc.'s experimental vaccine to prevent shingles can cut the rate of infection by about half in people 60 and older and help curb related pain, U.S. regulatory staff said in documents released on Wednesday. But company data also showed the vaccine, called Zostavax, did not significantly reduce rates of death or hospitalization and became less effective after three years, U.S. Food and Drug Administration staff said...


Latest Varicella zoster virus Reference Libraries

69_7b87211f9314eacab994d465558a3a1b
2011-01-24 12:56:26

Herpes zoster (or zoster), is known as shingles or zona and is a viral disease characterized by painful skin rash with blisters in a limited area on one side of the body. Initial infection causes chickenpox. Once chickenpox is over the virus remains in the body and can cause shingles. It can become latent in the nerve cell bodies and sometimes in the dorsal root, cranial nerve, or autonomic ganglion. Years after initial infection, another breakout can cause a painful rash. The rash usually...

More Articles (1 articles) »